Related Articles Pharmacotherapy-Based Problems in the Management of Diabetes Mellitus: Needs Much More to be Done! Saroglitazar, a novel cardiometabolic agent for diabetic dyslipidemia – A Review Share 0 FacebookTwitterLinkedinEmail Previous Article Next Article